文献速递新生儿儿童内分泌与遗传代谢

新生儿低血糖风险者连续葡萄糖监测的可行性研究

Continuous glucose monitoring in neonates at risk of hypoglycaemia: a feasibility study
RSS 订阅 · ADC Fetal and Neonatal

该研究探讨了在低血糖风险新生儿中使用连续葡萄糖监测(CGM)的可行性,发现CGM测得的组织葡萄糖准确度随出生后日龄增加而逐步改善,并能检测到常规血糖监测时段之外的无声低血糖事件。

要点

  • CGM在低血糖风险新生儿中可行,准确度随日龄增加而改善。
  • CGM可检测常规监测时段外的无声低血糖事件。
  • 低血糖范围灵敏度更高的CGM可能作为毛细血管采血的安全辅助手段。

核心结论

  • CGM在低血糖风险新生儿中具有可行性,其组织葡萄糖测量准确度随出生后日龄增加而逐步改善。
  • CGM可检测到常规血糖监测时段之外的无声低血糖事件。
  • 低血糖范围灵敏度更高的CGM可能作为毛细血管采血的安全可行辅助手段。

研究设计与样本

  • 研究为可行性研究,纳入有低血糖风险的新生儿。

主要发现

  • CGM测得的组织葡萄糖准确度随出生后日龄增加而逐步改善。
  • CGM检测到常规血糖监测时段之外的无声低血糖事件。

关键数值与推荐

  • 低血糖发生于5–15%的新生儿中,在有危险因素者中高达50%。

临床怎么用

  • 低血糖范围灵敏度更高的CGM可作为毛细血管采血的安全可行辅助手段,帮助监测有低血糖风险的新生儿。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

WHAT IS ALREADY KNOWN ON THIS TOPIC Continuous glucose monitoring (CGM) devices are applied in several clinical situations in neonatal intensive care units, although devices are not specifically designed for use in neonates. WHAT THIS STUDY ADDS The accuracy of tissue glucose measurements obtained through CGM progressively improved with advancing postnatal age. CGM detected silent hypoglycaemic episodes in at-risk neonates beyond conventional glucose monitoring period. HOW THIS STUDY MIGHT AFFECT RESEARCH, PRACTICE OR POLICY CGM with higher sensitivity in the lower range could be a safe and feasible adjunct to capillary blood sampling to aid glucose monitoring in neonates at risk of hypoglycaemia. Introduction Hypoglycaemia occurs in 5–15% of all neonates and as many as 50% of those with risk factors. 1 2 After birth, the neonate adapts from maternal glucose supply to independent conditions. Until breastfeeding...

来源:ADC Fetal and Neonatal,查看原文。版权归原作者所有。

引用

  1. ADC Fetal and Neonatal:Continuous glucose monitoring in neonates at risk of hypoglycaemia: a feasibility study

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。